Medical Weight Loss for Kodiak, Alaska Residents
Kodiak, Alaska residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Kodiak through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Kodiak Residents Choose New Hope Weight Loss
New Hope Weight Loss is a physician-supervised medical weight loss clinic in Costa Mesa, California that has treated over 5,400 patients since 2020. We serve Kodiak, Alaska through telehealth at some of the most transparent prices anywhere, semaglutide from $166/month and tirzepatide from $233/month · just $7.70/day. No insurance battles, no hidden fees. Care is overseen by Dr. Anjmun Sharma, M.D.
Kodiak is part of the area New Hope Weight Loss serves by telehealth. The same compounded semaglutide and tirzepatide protocols, the same flat pricing, and the same bilingual support reach Kodiak patients at home.
In Kodiak, Alaska, you do not need a local clinic to begin: our physician-led program reaches you by telehealth. We care for patients throughout Kodiak and the Kodiak Island area. Whether you are starting your first GLP-1 program or switching from a brand medication, your Kodiak treatment plan is built around your health history and goals.
For Kodiak residents, being seen by video means starting this week instead of waiting for an in-person appointment. Compounded medication arrives in discreet, cold-pack packaging at your Kodiak address, usually within days.
GLP-1 Weight Loss Programs Available
Semaglutide (90-Day Metabolic Reset), from $166/mo
Our most popular program for Kodiak patients uses semaglutide, the same active ingredient found in Wegovy® and Ozempic®. In clinical trials of the branded drug, patients lost an average of 15-17% of body weight, with physician oversight and monthly dose adjustments.
Tirzepatide (Advanced Program), from $233/mo
For maximum results, tirzepatide uses a dual GLP-1/GIP mechanism that clinical trials showed can reach up to 22.5% body-weight loss.
Doctor review: $119. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.
How Telehealth Works for Kodiak
First, you complete the online medical intake in a few minutes. Next, Dr. Sharma reviews your history by secure video, usually within 48 hours. If you are a candidate and telehealth-eligible, your compounded medication ships to your Kodiak address in cold-pack packaging, and follow-ups and dose adjustments continue by video, with no travel.
Frequently Asked Questions, Kodiak
Does New Hope Weight Loss treat patients in Kodiak?
Yes. Although the clinic is in Costa Mesa, California, we treat Kodiak, Alaska residents by telehealth, Dr. Sharma reviews your case by secure video and compounded medication ships to your home. Eligibility is confirmed during the consultation.
Do I have to travel to get started from Kodiak?
No travel is needed. The whole process, intake, consultation, and follow-ups, is by secure video, and your medication arrives at your Kodiak address in cold-pack packaging.
What do Kodiak patients pay?
Flat nationwide pricing: $119 for the physician review, then semaglutide from $166/month and tirzepatide from $233/month, medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, with no distance surcharge.
What areas of Kodiak do you serve?
We serve patients from across Kodiak by telehealth, including Kodiak and the Kodiak Island area.
How soon can a Kodiak patient start treatment?
Most Kodiak patients complete the online intake in minutes and have Dr. Sharma's video review within about 48 hours. If you are a candidate and telehealth-eligible, medication ships shortly after, so many patients begin within roughly a week of starting.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Kodiak, Alaska by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.